Giovanardi Carlo Maria, Cinquini Michela, Aguggia Marco, Allais Gianni, Campesato Manuela, Cevoli Sabina, Gentili Fabio, Matrà Annunzio, Minozzi Silvia
Italian Federation of Acupuncture Societies, Bologna, Italy.
Laboratory of Clinical Research Methodology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Front Neurol. 2020 Dec 15;11:576272. doi: 10.3389/fneur.2020.576272. eCollection 2020.
Migraine is a chronic paroxymal neurological disorder characterized by attacks of moderate to severe headache and reversible neurological and systemic symptoms. Treatment of migraine includes acute therapies, that aim to reduce the intensity of pain of each attack, and preventive therapies that should decrease the frequency of headache recurrence. The objective of this systematic review was to assess the efficacy and safety of acupuncture for the prophylaxis of episodic or chronic migraine in adult patients compared to pharmacological treatment. We included randomized-controlled trials published in western languages that compared any treatment involving needle insertion (with or without manual or electrical stimulation) at acupuncture points, pain points or trigger points, with any pharmacological prophylaxis in adult (≥18 years) with chronic or episodic migraine with or without aura according to the criteria of the International Headache Society. Nine randomized trials were included encompassing 1,484 patients. At the end of intervention we found a small reduction in favor of acupuncture for the number of days with migraine per month: (SMD: -0.37; 95% CI -1.64 to -0.11), and for response rate (RR: 1.46; 95% CI 1.16-1.84). We found a moderate effect in the reduction of pain intensity in favor of acupuncture (SMD: -0.36; 95% CI -0.60 to -0.13), and a large reduction in favor of acupuncture in both the dropout rate due to any reason (RR 0.39; 95% CI 0.18 to 0.84) and the dropout rate due to adverse event (RR 0.26; 95% CI 0.09 to 0.74). Quality of evidence was moderate for all these primary outcomes. Results at longest follow-up confirmed these effects. Based on moderate certainty of evidence, we conclude that acupuncture is mildly more effective and much safer than medication for the prophylaxis of migraine.
偏头痛是一种慢性发作性神经疾病,其特征为中度至重度头痛发作以及可逆性神经和全身症状。偏头痛的治疗包括旨在减轻每次发作疼痛强度的急性疗法,以及应减少头痛复发频率的预防性疗法。本系统评价的目的是评估与药物治疗相比,针刺疗法预防成年患者发作性或慢性偏头痛的疗效和安全性。我们纳入了以西方语言发表的随机对照试验,这些试验将涉及在穴位、痛点或触发点进行针刺(有或无手动或电刺激)的任何治疗,与根据国际头痛协会标准对有或无先兆的慢性或发作性偏头痛成年患者(≥18岁)进行的任何药物预防进行比较。纳入了9项随机试验,共1484例患者。在干预结束时,我们发现针刺疗法在每月偏头痛天数方面有小幅减少(标准化均数差:-0.37;95%可信区间-1.64至-0.11),在缓解率方面也有小幅减少(相对危险度:1.46;95%可信区间1.16-1.84)。我们发现针刺疗法在减轻疼痛强度方面有中度效果(标准化均数差:-0.36;95%可信区间-0.60至-0.13),在因任何原因导致的退出率(相对危险度0.39;95%可信区间0.18至0.84)和因不良事件导致的退出率(相对危险度0.26;95%可信区间0.09至0.74)方面,针刺疗法均有大幅减少。所有这些主要结局的证据质量为中等。最长随访期的结果证实了这些效果。基于证据的中等确定性,我们得出结论,在偏头痛预防方面,针刺疗法比药物疗法略有效且安全得多。